`
`Administrative file for NDA 212690
`
`Vandna Kishore, Regulatory Health Project Manager
`Division of Neurology 1, Office of New Drugs
`
`DEPARTMENT OF HEALTH AND HUMAN SERVICES
`PUBLIC HEALTH SERVICE
`FOOD AND DRUG ADMINISTRATION
`CENTER FOR DRUG EVALUATION AND RESEARCH
`
`MEMORANDUM
`
`
`
`
`DATE:
`
`TO:
`
`FROM:
`
`
`SUBJECT: Officer/Employee List for NDA 212690
`
`APPLICATION/DRUG: NDA 212690, XYWAV™ (calcium, magnesium, potassium, and
`sodium oxybates), oral solution, 0.5 g/mL.
`
`
`
`The following officers or employees of FDA participated in the decision to approve this
`application and consented to be identified on this list:
`
`Last name, First name (alphabetize by last name)
`
`Alexander, John J
`Alfaro, Cara
`Ayalew, Kassa
`Bastings, Eric
`Banks-Muckenfuss, Melissa
`Bhattacharya, Nandini
`Blair, Joan E. (CDER)
`Bullock, Heather
`Carter, Lonice
`Chiou, Grace
`Falter, Rebecca
`Freed, Lois M
`Fritsch, Jeff
`Gottipati, Gopichand
`Heimann, Martha R
`Jin, Kun
`Kalonia, Justine
`Kishore, Vandna
`Mani, Ranjit
`McAlman, Carol
`Ogbonna, Casmir
`Pinto, Julia
`Reissig, Chad J.
`Sabarinath, Sreedharan
`
`Reference ID: 4644439
`
`
`
`Tamta, Hemlata
`Wackes, Frank
`Walker, Shetarra
`Wang, Joanne
`White, Lolita
`Williams, Marcia Britt
`Williams, Sharon
`Wilson, Wendy
`Yan, Sharon
`Yancy, Jacquline
`
`
`
`
`Reference ID: 4644439
`
`